Mounjaro injection for weight loss

Tirzepatide acts on hormone pathways involved in appetite, blood-sugar control, and digestion. It is given under the skin on a schedule chosen by a prescriber, with dose changes made gradually when appropriate. It is not suitable for everyone, and weight management works best when the medicine is part of an agreed plan involving food, movement, sleep, and follow-up. Related information is available in this guide to the [GLP-1 Receptor Agonist].

Use only the prescribed dose and injection schedule. Tell the clinician about diabetes medicines, digestive disorders, previous pancreatitis, gallbladder problems, kidney disease, pregnancy, or plans for pregnancy. Nausea, diarrhoea, constipation, reduced appetite, and vomiting can occur, particularly after a dose change. Drink fluids as advised and contact the prescriber if side effects make eating or drinking difficult. Do not share pens or use a product from an unverified source.

Seek urgent help for severe or persistent abdominal pain, repeated vomiting, swelling of the face or throat, trouble breathing, confusion, or signs of dehydration. Contact your prescriber promptly for severe stomach symptoms, yellowing of the skin or eyes, or a marked change in blood-sugar symptoms if you also use diabetes treatment.

Ask whether your health history makes tirzepatide appropriate, how the dose will be increased, what to do after a missed dose, and which symptoms require a call. Discuss whether a structured [Weight Management Programme] should accompany treatment.